Functional characterization of human immunodeficiency virus type 1 nef genes in patients with divergent rates of disease progression.

Por Michael, N L, Chang, G, d'Arcy, L A, Tseng, C J, Birx, D L, Sheppard, H W
Publicado em 1995

Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort.

Por Michael, N L, Mo, T, Merzouki, A, O'Shaughnessy, M, Oster, C, Burke, D S, Redfield, R R, Birx, D L, Cassol, S A
Publicado em 1995

Evolution of human immunodeficiency virus type 1 env sequence variation in patients with diverse rates of disease progression and T-cell function.

Por McDonald, R A, Mayers, D L, Chung, R C, Wagner, K F, Ratto-Kim, S, Birx, D L, Michael, N L
Publicado em 1997

Human immunodeficiency virus type 1 strains of subtypes B and E replicate in cutaneous dendritic cell-T-cell mixtures without displaying subtype-specific tropism.

Por Pope, M, Frankel, S S, Mascola, J R, Trkola, A, Isdell, F, Birx, D L, Burke, D S, Ho, D D, Moore, J P
Publicado em 1997

Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus.

Por Michael, N L, Chang, G, d'Arcy, L A, Ehrenberg, P K, Mariani, R, Busch, M P, Birx, D L, Schwartz, D H
Publicado em 1995

In-Depth, Longitudinal Analysis of Viral Quasispecies from an Individual Triply Infected with Late-Stage Human Immunodeficiency Virus Type 1, Using a Multiple PCR Primer Approach

Por Gerhardt, M., Mloka, D., Tovanabutra, S., Sanders-Buell, E., Hoffmann, O., Maboko, L., Mmbando, D., Birx, D. L., McCutchan, F. E., Hoelscher, M.
Publicado em 2005

Antibodies with specificity to native gp120 and neutralization activity against primary human immunodeficiency virus type 1 isolates elicited by immunization with oligomeric gp160.

Por VanCott, T C, Mascola, J R, Kaminski, R W, Kalyanaraman, V, Hallberg, P L, Burnett, P R, Ulrich, J T, Rechtman, D J, Birx, D L
Publicado em 1997

Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 a...

Por Mascola, J R, Louder, M K, VanCott, T C, Sapan, C V, Lambert, J S, Muenz, L R, Bunow, B, Birx, D L, Robb, M L
Publicado em 1997

High prevalence of HIV infection among rural tea plantation residents in Kericho, Kenya

Por FOGLIA, G., SATEREN, W. B., RENZULLO, P. O., BAUTISTA, C. T., LANGAT, L., WASUNNA, M. K., SINGER, D. E., SCOTT, P. T., ROBB, M. L., BIRX, D. L.
Publicado em 2008

Expansion of restricted cellular immune responses to HIV-1 envelope by vaccination: IL-7 and IL-12 differentially augment cellular proliferative responses to HIV-1

Por KIM, J H, LOVELAND, J E, SITZ, K V, RATTO KIM, S, MCLINDEN, R J, TENCER, K, DAVIS, K, BURKE, D S, BOSWELL, R N, REDFIELD, R R, BIRX, D L
Publicado em 1997

In-Depth Analysis of a Heterosexually Acquired Human Immunodeficiency Virus Type 1 Superinfection: Evolution, Temporal Fluctuation, and Intercompartment Dynamics from the Seronegat...

Por McCutchan, F. E., Hoelscher, M., Tovanabutra, S., Piyasirisilp, S., Sanders-Buell, E., Ramos, G., Jagodzinski, L., Polonis, V., Maboko, L., Mmbando, D., Hoffmann, O., Riedner, G., von Sonnenburg, F., Robb, M., Birx, D. L.
Publicado em 2005